Wednesday, November 26, 2025
HomeIndustriesBiotechnology

Biotechnology

Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer

Cogent Biosciences, Inc. a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the appointment of Cole Pinnow as Chief Commercial Officer....

Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics

Providence Therapeutic Holdings Inc., a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines and therapeutics, and the Ontario...

Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium...

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected to manufacture adeno-associated vectors...

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Owkin, the first end-to-end TechBio unicorn that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug...

Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery...
0FansLike
0FollowersFollow
spot_img

Hot Topics